Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck UTB Rollforward by Year
UTB Rollforward — Gross Decreases for Prior-Year Tax Positions ($M) ($M)
Merck UTB Rollforward: $94M in FY2025, up 184.8% from a year earlier.
Latest, FY2025
94
Period ended Dec 31, 2025
Change on a year earlier
+184.8%
33 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-K Taxes on Income Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | UTB Rollforward — Gross Decreases for Prior-Year Tax Positions ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 94 | +184.8% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 33 | +65.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 20 | -50.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 40 | -82.6% | Form 10-K (filed 2025-02-25) ↗ |
| FY2021 | Dec 31, 2021 | 230 | +5,650.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 4 | -99.1% | Form 10-K (filed 2023-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 454 | +521.9% | Form 10-K (filed 2022-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 73 | -93.0% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 1,038 | +1,053.3% | Form 10-K (filed 2020-02-26) ↗ |
| FY2016 | Dec 31, 2016 | 90 | – | Form 10-K (filed 2019-02-27) ↗ |
Cite this data
StockData. (2026). Merck UTB Rollforward ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/tax-utb-dec-prior
See every metric in the Merck KPI table. Data updated Oct 26, 2026.